Former Executive Vice President and Chief Medical Officer · Editas Medicine, Inc. (EDIT)

Baisong Mei

A named executive officer of Editas Medicine in every fiscal year CompBrief holds from FY2022 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$821,402

Salary $492,327Stock awards $75,332

FY2023: $1,141,405

3rd of 3 named executive officers at Editas Medicine by FY2024 total.

3 named officers on file for Editas Medicine, FY2024

Baisong Mei’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • EDIT’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Editas Medicine’s whole pay program stands against its peers

  • Editas Medicine’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on EDIT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 15, 2025 (DEF 14A).

Free

Get Baisong Mei’s full pay file as a PDF — free

More than this page: up to 10 years of Baisong’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Baisong Mei compensation by year

Editas Medicine Summary Compensation Table · all 3 fiscal years held
In US dollars, as Editas Medicine reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024
Salary$199,038$459,930$492,327
Bonus$100,000$0$0
Stock awards$874,996$156,960$75,332
Option awards$1,748,762$329,540$1,843
Non-equity incentive$84,240$186,995$243,000
Pension and deferred compensation$0$0$0
All other$3,711$7,980$8,900
Total$3,010,747$1,141,405$821,402

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Editas Medicine, Inc. DEF 14A filed April 15, 2025, accession 0001650664-25-000058, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Editas Medicine, Inc. filed document, accession 0001650664-25-000058. Every figure is read from that document and cited to the page and table it appears in. Filed April 15, 2025.

$3.0M
$1.1M
$821K
FY22
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU50,900$64,643—
PSU50,900$64,643—
PSU36,000$45,720—
RSU29,186$37,066—
PSU19,457$24,710—
RSU10,125$12,859—
Option67,926—$14.99
Option30,375—$8.72
Option124,150—$9.92

Per the Outstanding Equity Awards at Fiscal Year-End table in Editas Medicine, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Editas Medicine’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Gilmore O'NeillPresident and Chief Executive Officer$5,126,868
Erick LuceraFormer Executive Vice President and Chief Financial Officer$1,809,321
Baisong Mei · this pageFormer Executive Vice President and Chief Medical Officer$821,402

The full Editas Medicine compensation record

free company brief

This page is one person within Editas Medicine's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Editas Medicine proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Editas Medicine's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Baisong Mei's compensation dossier · One-time report. No refunds.